Alector
We are on a mission to make brain disorders history.
141 employees · est. 2013 · South San Francisco, United...
Korsana Biosciences
Therapeutics for neurodegenerative diseases targeting amyloid beta
26 employees · est. 2024 · Waltham, United States
Alector is the older company (2013 vs 2024); Alector is the larger of the two.
Side-by-Side Comparison
| Metric | Alector | Korsana Biosciences |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2024 |
| Headquarters | ||
| Headquarters | South San Francisco, United States | Waltham, United States |
| Employees | ||
| Employees | 141 larger | 26 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology |
| Funding Stage | ||
| Funding Stage | IPO | IPO |
| Total Funding | ||
| Total Funding | $495.50M | $555.00M |
| Funding Rounds | ||
| Funding Rounds | 8 | 3 |
| Services | ||
| Services | Development of therapies for neurodegenerative diseases, Conducting clinical trials, Research in human genetics, neuroscience, and immunology | Development of CNS-targeted therapeutics, Research and development of novel therapeutics, Partnerships for shuttle platform technologies |
| Target Customers | ||
| Target Customers | Patients with neurodegenerative diseases, Healthcare providers, Research institutions | Patients with neurodegenerative diseases, Caregivers, Healthcare providers, Pharmaceutical companies |
| Taxonomy | ||
| Taxonomy | Neurodegenerative Diseases, Clinical Development, Antibody Discovery, Protein Engineering, Blood-Brain Barrier Technology, Alzheimer's Disease, Neuroimmunology, Genetic Targeting, Therapeutic Development, Neuroscience, Innovative Therapies, Drug Development, Lysosomal Dysfunction, Immune System Restoration | Biopharmaceutical, Neurodegenerative Diseases, Amyloid Beta Targeting, Blood-Brain Barrier, Therapeutic Targeting, THETA Platform, Antibody Therapeutics, Alzheimer's Disease, Brain Drug Delivery, Precision Medicine, Shuttled Antibody, Pharmaceutical Development, Drug Pipeline |
| Website | ||
| Website | alector.com | korsana.com |
About Alector
Alector, founded in 2013 and headquartered in the United States, is a cutting-edge player in the Biotechnology sector, focused on transforming approaches to Health Care and Pharmaceuticals. With the bold mission "to make brain disorders history," Alector is anchored in a late-stage clinical phase wi...
About Korsana Biosciences
Korsana Biosciences, founded in 2024, is a groundbreaking private biopharmaceutical enterprise focused on developing cutting-edge therapies for neurodegenerative diseases. With its slogan, "Therapeutics for neurodegenerative diseases targeting amyloid beta," Korsana is pioneering in the Biotechnolog...
We will tell you when either one moves
BounceWatch watches Alector and Korsana Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Alector and Korsana Biosciences — by email.
Frequently Asked Questions
Compare Alector with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Alector on 16 Jun 2026, and Korsana Biosciences on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.